ATE424562T1 - Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern - Google Patents

Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern

Info

Publication number
ATE424562T1
ATE424562T1 AT00908836T AT00908836T ATE424562T1 AT E424562 T1 ATE424562 T1 AT E424562T1 AT 00908836 T AT00908836 T AT 00908836T AT 00908836 T AT00908836 T AT 00908836T AT E424562 T1 ATE424562 T1 AT E424562T1
Authority
AT
Austria
Prior art keywords
lysosomal storage
saposins
markers
diagnosis
lamps
Prior art date
Application number
AT00908836T
Other languages
English (en)
Inventor
Peter Meikle
John Hopwood
Bryan Winchester
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9908190.3A external-priority patent/GB9908190D0/en
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of ATE424562T1 publication Critical patent/ATE424562T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00908836T 1999-03-17 2000-03-17 Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern ATE424562T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12486499P 1999-03-17 1999-03-17
GBGB9908190.3A GB9908190D0 (en) 1999-04-09 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers

Publications (1)

Publication Number Publication Date
ATE424562T1 true ATE424562T1 (de) 2009-03-15

Family

ID=26315403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908836T ATE424562T1 (de) 1999-03-17 2000-03-17 Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern

Country Status (10)

Country Link
EP (1) EP1163527B1 (de)
JP (1) JP2010139511A (de)
KR (2) KR20080102423A (de)
AT (1) ATE424562T1 (de)
AU (1) AU776842B2 (de)
CA (1) CA2366232C (de)
DE (1) DE60041694D1 (de)
IL (2) IL145345A0 (de)
NZ (2) NZ514166A (de)
WO (1) WO2000055632A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001233715A1 (en) * 2000-01-26 2001-08-07 Memorec Medical Molecular Research Cologne Stoffel Gmbh Dermo- and gastro-specific sphingolipid activator
JP2005511012A (ja) 2001-08-10 2005-04-28 セローノ ジェネティクス インスティテュート ソシエテ アノニム ヒトｃＤＮＡおよびタンパク質およびその使用
AU2004225901B2 (en) * 2003-03-31 2010-04-15 Children Youth And Women's Health Service Incorporated Multiplex screening for lysosomal storage disorders (LSDs)
NZ543309A (en) 2003-03-31 2008-12-24 Womens & Childrens Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
US20080206776A1 (en) 2005-09-05 2008-08-28 Bio-Rad Pasteur Use of Both Rd9 and Is6110 as Nucleic Acid Targets for the Diagnosis of Tuberculosis, and Provision of Multiplex-Compliant Is6110 and Rd9 Targets
KR101659762B1 (ko) 2014-10-30 2016-09-26 전북대학교산학협력단 효모를 이용한 위해 미생물 검출방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2990692A (en) * 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
AU714818B2 (en) * 1996-05-17 2000-01-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers

Also Published As

Publication number Publication date
EP1163527B1 (de) 2009-03-04
WO2000055632A1 (en) 2000-09-21
IL145345A (en) 2006-08-01
NZ533214A (en) 2005-05-27
DE60041694D1 (de) 2009-04-16
JP2010139511A (ja) 2010-06-24
KR20020021775A (ko) 2002-03-22
EP1163527A4 (de) 2004-05-19
KR20080102423A (ko) 2008-11-25
AU3135700A (en) 2000-10-04
CA2366232C (en) 2010-01-12
EP1163527A1 (de) 2001-12-19
CA2366232A1 (en) 2000-09-21
IL145345A0 (en) 2002-06-30
AU776842B2 (en) 2004-09-23
NZ514166A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
ATE317451T1 (de) Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs
EP1316802A3 (de) Verfahren zur Analyse der Blutkoagluationsreaktion
ATE508202T1 (de) Verfahren zur diagnose von brustkrebs
WO2002057787A3 (en) Detection of survivin in the biological fluids of cancer patients
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
DE60322848D1 (de) System für kontinuierliche leistungstests
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
IL145345A0 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
NO20055025D0 (no) Multiplex screening for lysosomale lagringsforstyrrelser (LSD)
NO953770L (no) Analysemetode
ATE366745T1 (de) Mutant er-alpha und nachweissysteme für transaktivierung
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
WO2000026251A3 (en) A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
WO2001007644A3 (en) Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
WO2001038581A3 (en) Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
EP0774970A4 (de) Verfahren zur verwendung von hyaluronsäure zur detektion, lokalisation und diagnose von tumoren
NO20032391L (no) Ekspresjonsanalyse av KIAA-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
WO2003068958A1 (fr) Procede d'analyse d'un acide nucleique specifiant un gene presentant une modification de son niveau d'expression liee a la schizophrenie
DE60329224D1 (de) Verfahren zur Bestimmung von zirkulierender DNS in Plasma und zum Nachweis von Krebs
ATE392622T1 (de) Verfahren zur diagnose von leberfibrose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties